In Neurology, Adherence Is Not a Percentage. It Is a Seizure, a Relapse or a Fall.
A missed antiseizure dose can cost a patient their license and their job. A disease modifying therapy paused over an unresolved authorization can cost an MS patient a relapse. A Parkinson's regimen taken an hour late costs them the afternoon.
The conditions are progressive, the drugs are unforgiving about timing, and the visit interval is often six months. Almost everything that matters happens in the gap.
The Opportunity
The Conditions Progress on a Schedule the Appointment Calendar Ignores
Most neurologic disease changes slowly and then, briefly, quickly. A patient’s function drifts for months and the visit that would have caught it is scheduled for spring. Meanwhile the practical failures accumulate. An authorization lapses. A titration gets abandoned over side effects. Falls happen and nobody logs them. A caregiver quietly reaches their limit.
None of that requires a neurologist to detect. All of it requires somebody asking on a reliable schedule, and it determines what condition the patient is in when they finally reach the appointment. CareNexa supplies the people who ask.
Who Qualifies
Which of Your Patients Qualify
The populations where structured between visit contact changes trajectory:
Epilepsy on antiseizure medication:
Where adherence, seizure frequency and side effect tolerance drive everything, and a lapse has immediate consequences for safety and livelihood.
Multiple sclerosis on disease modifying therapy:
Where laboratory monitoring, infusion scheduling and authorization continuity decide whether treatment is actually continuous.
Parkinson's disease and related movement disorders:
Where medication timing, motor fluctuation, falls and the non-motor symptoms patients never raise all need attention between visits.
Stroke and TIA survivors in secondary prevention:
Where blood pressure, anticoagulation adherence and risk factor control determine recurrence. The strongest combined program fit in the specialty.
Chronic migraine on preventive therapy:
Where headache day counts and early tolerability decide whether the preventive is continued long enough to work.
Dementia with caregiver involvement:
Where the plan is executed by somebody other than the patient and caregiver capacity is the limiting factor on all of it.
Neuromuscular disease on chronic immunosuppression:
Myasthenia gravis and inflammatory neuropathies, where laboratory obligations and infection risk run continuously.
And who we would leave out:
Single episode or consultative patients with no ongoing management requirement.
Long stable patients on unchanged therapy with no second qualifying condition and no recent utilization.
Patients whose care is already coordinated by primary care or another specialist running an active program.
Program Fit
Where Each Program Does the Work
CCM carries the neurology program
Adherence and titration support, authorization and infusion logistics, the laboratory obligations that antiseizure and immunosuppressive agents carry, falls and home safety, driving and work questions routed back to you, coordination with physical, occupational and speech therapy, and caregiver support where the patient is not the one executing the plan.
Neurology accumulates services faster than most specialties, and the coordination between them is where plans fall apart. A single point of contact holding all of it is most of the value here.
RPM is strongest after stroke
Blood pressure is the highest yield measurement in neurology, because secondary prevention after stroke or TIA is where home readings change a regimen and where the outcome being prevented is a recurrent event. Weight and blood pressure also serve the substantial cardiometabolic share of a neurology panel. The device comes from us and costs the practice nothing.
Everything else marketed as neurologic monitoring needs care. Seizure diaries, headache diaries, tremor apps and consumer wearables produce useful information and sit under patient reported and therapeutic monitoring constructs rather than the physiologic monitoring codes. We will not present one as the other.
Monthly Touchpoint
What the Monthly Touchpoint Actually Covers
Neurology monthly contact is built around timing, counts and safety:
Medication adherence and timing.
When a dose is taken matters as much as whether it was. Parkinson’s regimens and antiseizure schedules fail on timing long before they fail on adherence.
Event frequency review.
Seizures, relapses, falls and headache days, counted against the patient’s own baseline as they happen rather than recalled at a visit six months later.
Side effect and titration tolerability.
Sedation, cognitive complaints, mood change and the specific effects that cause silent discontinuation during the weeks a new agent is being introduced.
Access and supply continuity.
Authorization status, specialty pharmacy delivery and infusion appointments, which are the usual reasons disease modifying therapy is interrupted.
Laboratory and safety monitoring.
Drug levels, blood counts, liver and renal function, and sodium where the agent requires it, tracked to a schedule rather than remembered.
Function, safety and caregiver capacity.
Driving status, falls and home hazards, swallowing difficulty, and how the person supporting the patient is coping.
Clinical value
What Changes
The pattern that recurs is a patient who stopped and did not say so. A month into a new antiseizure medication the sedation is worse than they expected, so they halve the dose themselves and wait for the appointment in April. A coordinator asking the specific question in week three finds it, and you get to decide whether to adjust, reassure or switch while the decision is still yours to make.
The second is the count. Patients recall seizure and headache frequency badly across a six month interval, and treatment decisions get made on that recall. Monthly contact produces a record collected as it happened, which changes the quality of what the next appointment is working from.
A seizure or headache diary is not remote physiologic monitoring. Symptom tracking is clinically valuable and belongs in the program, but it sits under a different code family than physiologic monitoring. If a vendor is presenting a diary app or a consumer wearable as a remote monitoring program, ask which physiologic measurement is transmitted and by which device. Your billing lead should confirm the construct before launch rather than after a denial.
Questions Neurology Practices Ask
Our visit intervals are six or twelve months. Is monthly contact too much?
For the enrolled cohort it is the entire point, since the interval is the problem the program addresses. It is also why the cohort should be narrow. We would rather enroll the patients whose condition is changing, who are mid titration, or who have had recent utilization, than everyone whose diagnosis technically qualifies. The staffing comes from us, so starting narrow costs you nothing in setup and makes the first quarter readable.
What counts as the second chronic condition for a neurology patient?
In most cases it is already documented. Hypertension, diabetes, depression, osteoporosis and cardiovascular disease are common across neurology panels, and the neurologic condition plus one of those meets the threshold. We confirm it patient by patient at screening rather than assuming from a problem list.
Can coordinators advise on driving or adjust antiseizure medication?
No to both. Driving questions carry legal and regulatory weight and route straight to you, and dose decisions never sit with a coordinator. What they do is screen against the criteria you set at onboarding and surface the seizure count, the adherence picture and the side effect history through the dashboard, so that you are deciding from complete information.
Our dementia patients cannot report reliably. Does the program still work?
Yes, with the caregiver as the contact, and this is one of the populations that benefits most. Consent arrangements need handling properly where capacity is in question, and we set that up at enrollment rather than discovering it on the first call.
Start With Your Stroke and TIA Secondary Prevention Patients
Blood pressure is the measurement, recurrence is the outcome, and it is the cohort where both programs run together most cleanly. One clinical team, one dashboard, staffed and documented by us, with the billing exported to your system.